Literature DB >> 16690499

A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation.

Yuko Shimizu1, Megumi Takeuchi, Miyuki Matsumura, Takahiko Tokuda, Makoto Iwata.   

Abstract

A growing body of literature has described familial leptomeningeal amyloidosis, a rare phenotype resulting from deposition of transthyretin (TTR) amyloid within the leptomeninges. We report herein the case of a patient with leptomeningeal amyloidosis presenting with hearing loss, asymmetrical polyneuropathy and sensory ataxia. This is the first Japanese case displaying TTR mutation at codon 25, replacing alanine with threonine. Neurophysiological examinations suggested demyelinating polyradiculoneuropathy, which improved dramatically after high-dose intravenous immunoglobulin treatment. Demyelinating polyneuropathy in our patient may be attributable to massive leptomeningeal amyloidosis, and no systemic organ involvement was identified. These characteristic clinical manifestations may have resulted from the Ala25Thr TTR gene mutation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690499     DOI: 10.1080/13506120600551814

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  8 in total

Review 1.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

2.  The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis.

Authors:  Kuan Fan; Haixia Zhu; Hongbo Xu; Ping Mao; Lamei Yuan; Hao Deng
Journal:  J Neurol       Date:  2018-11-23       Impact factor: 4.849

3.  Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis.

Authors:  E P Azevedo; J H Ledo; G Barbosa; M Sobrinho; L Diniz; A C C Fonseca; F Gomes; L Romão; F R S Lima; F L Palhano; S T Ferreira; D Foguel
Journal:  Cell Death Dis       Date:  2013-09-05       Impact factor: 8.469

Review 4.  The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy.

Authors:  Pablo Cisternas; Xavier Taylor; Cristian A Lasagna-Reeves
Journal:  Int J Mol Sci       Date:  2019-12-14       Impact factor: 5.923

Review 5.  Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations.

Authors:  Qi Qin; Cuibai Wei; YueShan Piao; Fang Lian; Hao Wu; Aihong Zhou; Fen Wang; Xiumei Zuo; Yue Han; Jihui Lyu; Dongmei Guo; Jianping Jia
Journal:  Neurologist       Date:  2021-09-07       Impact factor: 1.398

6.  Surgically treated intradural spinal manifestation of hereditary amyloidogenic transthyretin amyloidosis - A case report and scoping review of the literature.

Authors:  Stefanos Voglis; Yesim Yildiz; Fabio von Faber-Castell; Kim Jannis Harnisch; Luca Regli; David Bellut; Rahel Schwotzer; Menno R Germans
Journal:  Brain Spine       Date:  2022-02-28

7.  Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia.

Authors:  Jennifer L Ziskin; Michael D Greicius; Wan Zhu; Anna N Okumu; Christopher M Adams; Edward D Plowey
Journal:  Acta Neuropathol Commun       Date:  2015-07-10       Impact factor: 7.801

8.  Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.

Authors:  P McColgan; S Viegas; S Gandhi; K Bull; R Tudor; F Sheikh; J Pinney; M Fontana; D Rowczenio; J D Gillmore; J A Gilbertson; C J Whelan; S Shah; Z Jaunmuktane; J L Holton; J M Schott; D J Werring; P N Hawkins; M M Reilly
Journal:  J Neurol       Date:  2014-12-09       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.